Terms: = Head and neck cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Treatment
223 results:
1. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
[TBL] [Abstract] [Full Text] [Related]
2. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X
Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715
[TBL] [Abstract] [Full Text] [Related]
3. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study.
Chen QY; Guo SS; Luo Y; Qu S; Wu DH; Chen XZ; Chen DP; Qin XT; Lin Q; Jin F; Lin SJ; Yao ZF; Liu W; Maxwell Wang Z; Li BY; Xia M; Xu RH; Tang LQ; Mai HQ
Oral Oncol; 2024 Apr; 151():106723. PubMed ID: 38387261
[TBL] [Abstract] [Full Text] [Related]
5. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
Sun MY; Wang L; Shen ZY
Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
[TBL] [Abstract] [Full Text] [Related]
6. Hellebrigenin induces oral cancer cell apoptosis by modulating MAPK signalling and XIAP expression.
Hsieh MJ; Lin CC; Lo YS; Ho HY; Chuang YC; Chen MK
J Cell Mol Med; 2024 Jan; 28(2):e18071. PubMed ID: 38044583
[TBL] [Abstract] [Full Text] [Related]
7. Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Dietzschold M; Schönstein A; Heinz A; Vokuhl C; Pajtler KW; Harrabi S; Lin YL; Kalle TV; Hagen R; Ladenstein R; Kazanowska B; Ljungman G; Klingebiel T; Ebinger M; Koscielniak E; Münter M; Timmermann B;
Pediatr Blood Cancer; 2024 Jan; 71(1):e30742. PubMed ID: 37880926
[TBL] [Abstract] [Full Text] [Related]
8. Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.
Ferreira AMC; Altemani JMC; Macedo LT; Lourenço GJ; Lima CSP
Sci Rep; 2023 Oct; 13(1):16762. PubMed ID: 37798436
[TBL] [Abstract] [Full Text] [Related]
9. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
Reynolds JV; Preston SR; O'Neill B; Lowery MA; Baeksgaard L; Crosby T; Cunningham M; Cuffe S; Griffiths GO; Parker I; Risumlund SL; Roy R; Falk S; Hanna GB; Bartlett FR; Alvarez-Iglesias A; Achiam MP; Nilsson M; Piessen G; Ravi N; O'Toole D; Johnston C; McDermott RS; Turkington RC; Wahed S; Sothi S; Ford H; Wadley MS; Power D;
Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):1015-1027. PubMed ID: 37734399
[TBL] [Abstract] [Full Text] [Related]
10. Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.
Ge S; Wang K; Meng Y; He Z; Yang X; Shang W; Wang L
Med Oncol; 2023 Sep; 40(10):304. PubMed ID: 37733085
[TBL] [Abstract] [Full Text] [Related]
11. Caspase activation in tumour-infiltrating lymphocytes is associated with lymph node metastasis in oral squamous cell carcinoma.
Bhosale PG; Kennedy RA; Watt FM
J Pathol; 2023 Sep; 261(1):43-54. PubMed ID: 37443405
[TBL] [Abstract] [Full Text] [Related]
12. The feasibility of post-photodynamic therapy salvage esophagectomy in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Shigeno T; Kajiyama D; Sato K; Fujiwara N; Kinugasa Y; Yano T; Daiko H; Fujita T
Esophagus; 2023 Oct; 20(4):643-650. PubMed ID: 37391597
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma.
Kamarajah SK; Markar SR; Low D; Phillips AW
BJS Open; 2023 May; 7(3):. PubMed ID: 37341158
[TBL] [Abstract] [Full Text] [Related]
14. LncRNA fas-AS1 upregulated by its genetic variation rs6586163 promotes cell apoptosis in nasopharyngeal carcinoma through regulating mitochondria function and fas splicing.
Guo Z; Li Z; Zhang M; Bao M; He B; Zhou X
Sci Rep; 2023 May; 13(1):8218. PubMed ID: 37217794
[TBL] [Abstract] [Full Text] [Related]
15. Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy.
Sadeghirad H; Liu N; Monkman J; Ma N; Cheikh BB; Jhaveri N; Tan CW; Warkiani ME; Adams MN; Nguyen Q; Ladwa R; Braubach O; O'Byrne K; Davis M; Hughes BGM; Kulasinghe A
Front Immunol; 2023; 14():1135489. PubMed ID: 37153589
[TBL] [Abstract] [Full Text] [Related]
16. Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial.
Zhao W; Ke S; Cai X; Zuo Z; Shi W; Qiu H; Cai G; Gong Y; Wu Y; Ruan S; Chen Y
Radiother Oncol; 2023 Jul; 184():109679. PubMed ID: 37105302
[TBL] [Abstract] [Full Text] [Related]
17. Outcome prediction models incorporating clinical variables for head and neck Squamous cell Carcinoma: A systematic review of methodological conduct and risk of bias.
Aly F; Hansen CR; Al Mouiee D; Sundaresan P; Haidar A; Vinod S; Holloway L
Radiother Oncol; 2023 Jun; 183():109629. PubMed ID: 36934895
[TBL] [Abstract] [Full Text] [Related]
18. Semilicoisoflavone B Induces Apoptosis of Oral cancer Cells by Inducing ROS Production and Downregulating MAPK and Ras/Raf/MEK Signaling.
Hsieh MJ; Ho HY; Lo YS; Lin CC; Chuang YC; Abomughaid MM; Hsieh MC; Chen MK
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901935
[TBL] [Abstract] [Full Text] [Related]
19. Association of treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid cancer: A Single-Institution 21-Year Experience.
Wu SS; Lamarre ED; Yalamanchali A; Brauer PR; Hong H; Reddy CA; Yilmaz E; Woody N; Ku JA; Prendes B; Burkey B; Nasr C; Skugor M; Heiden K; Chute DJ; Knauf JA; Campbell SR; Koyfman SA; Geiger JL; Scharpf J
JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):300-309. PubMed ID: 36757708
[TBL] [Abstract] [Full Text] [Related]
20. The Oral PI3Kδ Inhibitor Linperlisib for the treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial.
Wang T; Sun X; Qiu L; Su H; Cao J; Li Z; Song Y; Zhang L; Li D; Wu H; Zhang W; Li J; Zhou K; Zhou H; Yang Y; Li Z; Cen H; Cai Z; Zhang Z; Fu W; Jin J; Li F; Wu W; Gu X; Zhu W; Liu L; Li Z; Yi S; Bao H; Xu Z; Qiu L
Clin Cancer Res; 2023 Apr; 29(8):1440-1449. PubMed ID: 36735519
[TBL] [Abstract] [Full Text] [Related]
[Next]
